Profile: Abeome Corporation is a biotechnology company that uses its hybridoma technology to develop monoclonal antibodies for life sciences and clinical medicine. Our DiSH technology is used for screening new targets and it can be used to identify the desired monoclonals by fluorescent labeled antigens to bind surface expressed antibodies, making isolation & cloning of desired cells significantly easier.